Physician profile
Lisa M Helmick
NPI 1265624050
$1,642.69
in general payments reported to CMS, 2019-2025
23 companies · $211 in 2025
The $211 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $450 · 2020: $28.91 · 2021: $95.85 · 2022: $79.62 · 2023: $507 · 2024: $270 · 2025: $211.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $988.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $988.43 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $365.41 | 2019-2025 | |
| Hologic Sales and Service, LLC | $204.02 | 2019-2024 | Coolseal Generator, Acessa Provu System |
| Gynesonics, INC. | $125.29 | 2023 | Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Pfizer INC. | $87.78 | 2019-2023 | |
| Mayne Pharma Commercial LLC | $85.23 | 2023-2025 | |
| Astellas Pharma US INC | $75.95 | 2023-2025 | Veozah |
| Therapeuticsmd, INC. | $72.20 | 2019 | |
| Exeltis, USA INC. | $71.49 | 2019-2025 | Slynd |
| Exact Sciences Corporation | $70.91 | 2023-2025 | Cologuard Collection Kit |
| Caldera Medical, INC | $58.00 | 2022 | |
| Channel Medsystems, INC. | $57.70 | 2025 | |
| Coopersurgical, INC. | $49.92 | 2024 | Paragard T 380a |
| Axonics, INC. | $39.51 | 2024 | Axonics |
| Ethicon US, LLC | $37.23 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $35.95 | 2020-2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Shield Therapeutics INC | $35.84 | 2023-2024 | Accrufer |
| Amgen INC. | $31.78 | 2019-2023 | Evenity, Prolia |
| Coloplast Corp | $30.47 | 2024 | |
| Millicent US INC | $29.95 | 2024-2025 | Femlyv, Femring, Intrarosa |
| Allergan, INC. | $29.27 | 2019 | |
| Medicem INC. | $20.10 | 2023 | |
| Organon LLC | $15.20 | 2023 | Nexplanon |
| Lupin INC. | $13.49 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Helmick listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.